Treatment costs and clinical outcome for first episode schizophrenia patients: a 3-year follow-up of the Swedish ‘Parachute Project’ and Two Comparison Groups
Article first published online: 7 APR 2006
Acta Psychiatrica Scandinavica
Volume 114, Issue 4, pages 274–281, October 2006
How to Cite
Cullberg, J., Mattsson, M., Levander, S., Holmqvist, R., Tomsmark, L., Elingfors, C. and Wieselgren, I.-M. (2006), Treatment costs and clinical outcome for first episode schizophrenia patients: a 3-year follow-up of the Swedish ‘Parachute Project’ and Two Comparison Groups. Acta Psychiatrica Scandinavica, 114: 274–281. doi: 10.1111/j.1600-0447.2006.00788.x
- Issue published online: 7 APR 2006
- Article first published online: 7 APR 2006
- Accepted for publication January 25, 2006
- first episode schizophrenia;
- neuroleptic treatment;
- treatment costs
Objective: To evaluate ‘need-specific treatment’ of first episode schizophrenia syndrome patients.
Method: Sixty-one consecutive first episode schizophrenia syndrome patients were followed over 3 years. They were compared with a Historical ‘treatment as usual’ group (n = 41) and a Prospective group from a high quality social and biological psychiatry centre (n = 25).
Results: Symptomatic and functional outcome was significantly better compared with the Historical group and equal with the Prospective group. During the first year, the direct costs for in- and out-patient care per patient in the Parachute project were less than half of those in the Prospective group.
Conclusion: The study confirms the feasibility, clinically and economically, with a large scale application of ‘need-specific treatments’ for first episode psychotic patients.